Licensee Development Sample Clauses
Licensee Development. Licensee will conduct its Development activities with respect to each Licensed Compound and Licensed Product in a manner so as to seek and maintain Regulatory Approvals that include an appropriate label in each applicable Indication in light of available clinical data. As between the Parties, Licensee will be solely responsible for: (a) all activities related to the Development of the Licensed Compounds and Licensed Products in the Field in the Licensee Territory; (b) all activities related to the Development of the TAK-385 Licensed Compound and TAK-385 Licensed Products through the receipt of Regulatory Approval in the Men’s Health Field in the Takeda Territory ((a) and (b), the “Licensee Development Activities”); and (c) all expenses, including Third Party expenses, related to such Development activities in (a), (b), and (c).
Licensee Development. Subject to the terms and conditions of this Agreement, Somaxon hereby grants to Licensee a non-exclusive right and license, with the right to sublicense solely upon the prior written consent of Somaxon, not to be unreasonably withheld, delayed or conditioned, under the Licensed Technology to conduct in the Territory any and all trials, studies and other requirements necessary for Regulatory Approval, in the case of each such trial, study or requirement, with the prior written consent of Somaxon, not to be unreasonably withheld, delayed or conditioned. Licensee shall from time to time notify Somaxon of the progress of such Licensee development activities after their commencement.
Licensee Development. Licensee (itself or through its Affiliates or sublicensees) shall be solely responsible for: (a) all of Licensee’s, and its Affiliates’ and their respective sublicensees’ and Third Party contractors’ activities related to the Development of the Compound and the Product in the Field in the Territory; and (b) all expenses, including Third Party expenses, related to such Development activities. Notwithstanding the foregoing, Takeda will be responsible for all activities and costs related to the Designated Clinical Trial.